13-23335854-A-G

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2

The NM_014363.6(SACS):​c.8022T>C​(p.Phe2674Phe) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000733 in 1,614,020 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00079 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00073 ( 4 hom. )

Consequence

SACS
NM_014363.6 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:5

Conservation

PhyloP100: 0.690

Publications

3 publications found
Variant links:
Genes affected
SACS (HGNC:10519): (sacsin molecular chaperone) This gene encodes the sacsin protein, which includes a UbL domain at the N-terminus, a DnaJ domain, and a HEPN domain at the C-terminus. The gene is highly expressed in the central nervous system, also found in skin, skeletal muscles and at low levels in the pancreas. This gene includes a very large exon spanning more than 12.8 kb. Mutations in this gene result in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS), a neurodegenerative disorder characterized by early-onset cerebellar ataxia with spasticity and peripheral neuropathy. The authors of a publication on the effects of siRNA-mediated sacsin knockdown concluded that sacsin protects against mutant ataxin-1 and suggest that "the large multi-domain sacsin protein is able to recruit Hsp70 chaperone action and has the potential to regulate the effects of other ataxia proteins" (Parfitt et al., PubMed: 19208651). A pseudogene associated with this gene is located on chromosome 11. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]
SACS Gene-Disease associations (from GenCC):
  • Charlevoix-Saguenay spastic ataxia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, PanelApp Australia, G2P, Myriad Women’s Health, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.62).
BP6
Variant 13-23335854-A-G is Benign according to our data. Variant chr13-23335854-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 285243.
BP7
Synonymous conserved (PhyloP=0.69 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000794 (121/152318) while in subpopulation AMR AF = 0.00222 (34/15296). AF 95% confidence interval is 0.00163. There are 0 homozygotes in GnomAd4. There are 61 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 4 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014363.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SACS
NM_014363.6
MANE Select
c.8022T>Cp.Phe2674Phe
synonymous
Exon 10 of 10NP_055178.3
SACS
NM_001437336.1
c.8049T>Cp.Phe2683Phe
synonymous
Exon 11 of 11NP_001424265.1A0A804HIQ1
SACS
NM_001278055.2
c.7581T>Cp.Phe2527Phe
synonymous
Exon 8 of 8NP_001264984.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SACS
ENST00000382292.9
TSL:5 MANE Select
c.8022T>Cp.Phe2674Phe
synonymous
Exon 10 of 10ENSP00000371729.3Q9NZJ4-1
SACS
ENST00000455470.6
TSL:1
c.2431+5591T>C
intron
N/AENSP00000406565.2H0Y6M8
SACS
ENST00000682944.1
c.8049T>Cp.Phe2683Phe
synonymous
Exon 11 of 11ENSP00000507173.1A0A804HIQ1

Frequencies

GnomAD3 genomes
AF:
0.000795
AC:
121
AN:
152200
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000217
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00223
Gnomad ASJ
AF:
0.00835
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000456
Gnomad OTH
AF:
0.00718
GnomAD2 exomes
AF:
0.00101
AC:
253
AN:
251014
AF XY:
0.000877
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.00208
Gnomad ASJ exome
AF:
0.00784
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000697
Gnomad OTH exome
AF:
0.00245
GnomAD4 exome
AF:
0.000727
AC:
1062
AN:
1461702
Hom.:
4
Cov.:
37
AF XY:
0.000675
AC XY:
491
AN XY:
727134
show subpopulations
African (AFR)
AF:
0.000269
AC:
9
AN:
33472
American (AMR)
AF:
0.00221
AC:
99
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.00704
AC:
184
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.000197
AC:
17
AN:
86252
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53396
Middle Eastern (MID)
AF:
0.00434
AC:
25
AN:
5766
European-Non Finnish (NFE)
AF:
0.000558
AC:
620
AN:
1111898
Other (OTH)
AF:
0.00179
AC:
108
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
70
139
209
278
348
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000794
AC:
121
AN:
152318
Hom.:
0
Cov.:
33
AF XY:
0.000819
AC XY:
61
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.000216
AC:
9
AN:
41584
American (AMR)
AF:
0.00222
AC:
34
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00835
AC:
29
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000456
AC:
31
AN:
68002
Other (OTH)
AF:
0.00711
AC:
15
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
5
10
16
21
26
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000818
Hom.:
0
Bravo
AF:
0.000967
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.000927
EpiControl
AF:
0.000949

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
2
Charlevoix-Saguenay spastic ataxia (3)
-
1
1
not provided (2)
-
1
-
Hereditary spastic paraplegia (1)
-
-
1
not specified (1)
-
-
1
Spastic paraplegia (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.62
CADD
Benign
4.2
DANN
Benign
0.59
PhyloP100
0.69
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34928783; hg19: chr13-23909993; COSMIC: COSV101207147; API